3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
192
Active not recruiting
65
Completed
50
Not yet recruiting
40
Enrolling by invitation
15
Terminated
7
Suspended
4
Withdrawn
3
Available
2
Sponsor Class
OTHER
3
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
2
Conditions
Prostatic Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Recurrence
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Thrombocytopenia
1
Sinusitis
1
Rib Fractures
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Oligodendroglioma
1
Non-Muscle Invasive Bladder Neoplasms
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, B-Cell
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Glioblastoma
1
Desmoid Tumors
1
Cytopenia
1
Communication Disorders
1
Colorectal Neoplasms
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Withdrawn
×
Neoplasms
×
30 days
×
Clear all
NCT05454163
2026-05-22
PRRSC
University Hospital, Lille
Withdrawn
NCT04488224
2026-05-19
Nano-X IG
University of Sydney
Phase EARLY_PHASE1
Withdrawn
NCT05495802
2026-05-15
OOSLOH
University Hospital, Lille
Withdrawn